The US Food and Drug Administration has granted full approval to the BioNTech/Pfizer Covid-19 vaccine, in a step that could encourage reluctant people to get immunised.
Since December, the two-dose BioNTech/Pfizer jab has been administered under an emergency use authorisation, given the urgent need for a vaccine to combat the pandemic.
Monday’s decision gives full approval to the mRNA jab for use in people aged over 16, the first Covid-19 vaccine to receive that designation. It continues to be used for children aged 12-15, and as a booster shot for people with weakened immune systems, under the emergency authorisation.
您已閱讀38%（624字），剩余62%（1014字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。